Psoriasis Clinical Trial

Topical CP-690,550 For Chronic Plaque Psoriasis

Summary

Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Having chronic plaque psoriasis for at least 6 months
Able to withdraw all prior psoriasis treatments
Must agree to avoid prolonged exposure to the sun and avoid use of tanning booths or other ultraviolet light sources during the study

Exclusion Criteria:

Evidence of active, latent, or inadequately treated infection with Mycobacterium tuberculosis
Pregnant or lactating women
Unwilling to use appropriate contraceptive methods

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

81

Study ID:

NCT00678561

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 19 Locations for this study

See Locations Near You

University of California Irvine
Irvine California, 92697, United States
Therapeutics Clinical Research
San Diego California, 92123, United States
RUSH University Medical Center
Chicago Illinois, 60612, United States
Tufts Medical Center
Boston Massachusetts, 02111, United States
University of Michigan
Ann Arbor Michigan, 48109, United States
Minnesota Clinical Study Center
Fridley Minnesota, 55432, United States
Central Dermatology, PC
Saint Louis Missouri, 63117, United States
Dermatology Consulting Services
High Point North Carolina, 27262, United States
The Imaging Center
High Point North Carolina, 27262, United States
Wake Forest University Health Sciences
Winston-Salem North Carolina, 27157, United States
Oregon Medical Research Center, PC
Portland Oregon, 97223, United States
Oregon Health & Science University
Portland Oregon, 97239, United States
DermResearch, Inc.
Austin Texas, 78759, United States
University of Utah School of Medicine
Salt Lake City Utah, 84132, United States
Guildford Dermatology Specialists
Surrey British Columbia, V3R 6, Canada
NewLab Clinical Research Inc.
St. John's Newfoundland and Labrador, A1C 2, Canada
K.Papp Clinical Research Inc.
Waterloo Ontario, N2J 1, Canada
Innovaderm Research, Inc.
Montreal Quebec, H2K 4, Canada
Siena Medical Research
Montreal Quebec, H3Z 2, Canada
Centre de Recherche Dermatologique du Quebec metropolitain
Quebec , G1V 4, Canada

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

81

Study ID:

NCT00678561

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider